| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |